Toby Michael Maher
Toby Michael Maher
Keck Medicine of University of Southern California
Verified email at - Homepage
Cited by
Cited by
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ...
New England Journal of Medicine 370 (22), 2071-2082, 2014
Interstitial lung disease in systemic sclerosis: a simple staging system
NSL Goh, SR Desai, S Veeraraghavan, DM Hansell, SJ Copley, ...
American journal of respiratory and critical care medicine 177 (11), 1248-1254, 2008
Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report
HR Collard, CJ Ryerson, TJ Corte, G Jenkins, Y Kondoh, DJ Lederer, ...
American journal of respiratory and critical care medicine 194 (3), 265-275, 2016
Nintedanib for systemic sclerosis–associated interstitial lung disease
O Distler, KB Highland, M Gahlemann, A Azuma, A Fischer, MD Mayes, ...
New England Journal of Medicine 380 (26), 2518-2528, 2019
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
TE Fingerlin, E Murphy, W Zhang, AL Peljto, KK Brown, MP Steele, ...
Nature genetics 45 (6), 613-620, 2013
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
PL Molyneaux, MJ Cox, SAG Willis-Owen, P Mallia, KE Russell, ...
American journal of respiratory and critical care medicine 190 (8), 906-913, 2014
Pulmonary fibrosis secondary to COVID-19: a call to arms?
P Spagnolo, E Balestro, S Aliberti, E Cocconcelli, D Biondini, ...
The Lancet Respiratory Medicine 8 (8), 750-752, 2020
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
TM Maher, AU Wells, GJ Laurent
European Respiratory Journal 30 (5), 835-839, 2007
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury
CJ Scotton, MA Krupiczojc, M Königshoff, PF Mercer, YCG Lee, ...
The Journal of clinical investigation 119 (9), 2550-2563, 2009
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes
TL Reddy, M Tominaga, DM Hansell, J von der Thusen, D Rassl, ...
European Respiratory Journal 40 (2), 377-385, 2012
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
TM Maher, TJ Corte, A Fischer, M Kreuter, DJ Lederer, M Molina-Molina, ...
The lancet Respiratory medicine 8 (2), 147-157, 2020
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
RG Jenkins, JK Simpson, G Saini, JH Bentley, AM Russell, R Braybrooke, ...
The lancet Respiratory medicine 3 (6), 462-472, 2015
Rituximab in severe, treatment‐refractory interstitial lung disease
GJ Keir, TM Maher, D Ming, R Abdullah, A de Lauretis, ...
Respirology 19 (3), 353-359, 2014
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised …
AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ...
The lancet Respiratory medicine 8 (5), 453-460, 2020
Short‐term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis
NS Goh, RK Hoyles, CP Denton, DM Hansell, EA Renzoni, TM Maher, ...
Arthritis & Rheumatology 69 (8), 1670-1678, 2017
Pulmonary macrophages: a new therapeutic pathway in fibrosing lung disease?
AJ Byrne, TM Maher, CM Lloyd
Trends in molecular medicine 22 (4), 303-316, 2016
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis
A De Lauretis, P Sestini, P Pantelidis, R Hoyles, DM Hansell, NSL Goh, ...
The Journal of rheumatology 40 (4), 435-446, 2013
Lysophosphatidic acid induces αvβ6 integrin-mediated TGF-β activation via the LPA2 receptor and the small G protein Gαq
MY Xu, J Porte, AJ Knox, PH Weinreb, TM Maher, SM Violette, ...
The American journal of pathology 174 (4), 1264-1279, 2009
Significance of connective tissue disease features in idiopathic interstitial pneumonia
TJ Corte, SJ Copley, SR Desai, CJ Zappala, DM Hansell, AG Nicholson, ...
European Respiratory Journal 39 (3), 661-668, 2012
Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis
TM Maher, IC Evans, SE Bottoms, PF Mercer, AJ Thorley, AG Nicholson, ...
American journal of respiratory and critical care medicine 182 (1), 73-82, 2010
The system can't perform the operation now. Try again later.
Articles 1–20